'Make your mess your message:' Robin Roberts shares powerful message during Ohio visit

Robin Roberts, the beloved host of "Good Morning America," recently visited New Albany to speak at the New Albany ...
CURE

FDA Grants Orphan Drug Designation to MNV-201 for Myelodysplastic Syndrome

The U.S. Food and Drug Administration has granted orphan drug designation to the investigational therapy MNV-201 for patients with myelodysplastic syndrome, a serious, age-related blood disorder that ...
The American Journal of Managed Care

Genetic Testing for Hereditary Cancer Identifies Case of MDS

Personalized treatment strategies are increasingly important in managing lung cancer brain metastases, incorporating targeted therapies and immunotherapies. Stereotactic radiosurgery and whole-brain ...
Targeted Oncology

FDA Grants Orphan Drug Status for MNV-201 in Low-Risk MDS

Orphan drug designation provides benefits such as tax credits, PDUFA fee waivers, and 7 years of market exclusivity upon ...
Targeted Oncology

Managing Adverse Events for Patients With MDS Given Imetelstat

Close monitoring via weekly complete blood counts (CBCs) for the first 2 months is essential to mitigate risks, according to Zeidan. Supportive care such as platelet transfusions or growth factors may ...
Morningstar

Florida Cancer Specialists & Research Institute Utilizes Proprietary Real-World Data in First Study of Treatment Response in Lower-Risk Myelodysplastic Syndrome Patients ...

FORT MYERS, Fla., Sept. 22, 2025 /PRNewswire/ -- Leveraging its proprietary real-world data, Florida Cancer Specialists & Research Institute, LLC (FCS) has concluded the first study to evaluate the ...